The calls for a national track-and-trace system, which had died down when legislation was nixed last year, have been revived after more counterfeit cancer drugs have been discovered in the U.S. Story | Special Report
| Thursday, June 11th | 1pm ET / 10am PT | Sponsored by: Catalent
This webinar will review regulatory guidance and practical strategies for designing viral clearance studies. These include appropriate scale-down of unit operations, virus spike-related considerations and validation (clearance evaluation) of manufacturing process steps. Reserve Your Spot Today!
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!